How to respond to abnormal liver function tests

被引：21

作者：

Collier, J ^{[1
]}

Bassendine, M

机构：

[1] John Radcliffe Hosp, Oxford OX3 9DU, England

[2] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England

[3] Univ Newcastle Upon Tyne, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

来源：

CLINICAL MEDICINE | 2002年 / 2卷 / 05期

关键词：

alcoholic liver disease; alkaline phosphatase; aminotransferases; chronic liver disease; hepatitis; liver function tests;

D O I：

10.7861/clinmedicine.2-5-406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：406 / 409

页数：4

共 11 条

[1] Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions [J].

Aithal, GP ;

Rawlins, MD ;

Day, CP .

JOURNAL OF HEPATOLOGY, 2000, 33 (06) :949-952

[2] International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis [J].

Alvarez, E ;

Berg, PA ;

Bianchi, FB ;

Bianchi, L ;

Burroughs, AK ;

Cancado, EL ;

Chapman, RW ;

Cooksley, WGE ;

Czaja, AJ ;

Desmet, VJ ;

Donaldson, RT ;

Eddleston, ALWF ;

Fainboim, L ;

Heathcote, J ;

Homberg, JC ;

Hoofnagle, JH ;

Kakumu, S ;

Krawitt, EL ;

Mackay, IR ;

MacSween, RNM ;

Maddrey, WC ;

Manns, MP ;

McFarlane, IG ;

zum Büschenfelde, KHM ;

Mieli-Vergani, G ;

Nakanuma, Y ;

Nishioka, M ;

Penner, E ;

Porta, G ;

Portmann, BC ;

Reed, WD ;

Rodes, J ;

Schalm, SW ;

Scheuer, PJ ;

Schrumpf, E ;

Seki, T ;

Toda, G ;

Tsuji, T ;

Tygstrup, N ;

Vergani, D ;

Zeniya, M .

JOURNAL OF HEPATOLOGY, 1999, 31 (05) :929-938

[3] Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].

Bruix, J ;

Sherman, M ;

Llovet, JM ;

Beaugrand, M ;

Lencioni, R ;

Burroughs, AK ;

Christensen, E ;

Pagliaro, L ;

Colombo, M ;

Rodés, J .

JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430

[4] Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis [J].

Guyader, D ;

Jacquelinet, C ;

Moirand, R ;

Turlin, B ;

Mendler, MH ;

Chaperon, J ;

David, V ;

Brissot, P ;

Adams, P ;

Deugnier, Y .

GASTROENTEROLOGY, 1998, 115 (04) :929-936

[5] Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study [J].

Imbert-Bismut, F ;

Ratziu, V ;

Pieroni, L ;

Charlotte, F ;

Benhamou, Y ;

Poynard, T .

LANCET, 2001, 357 (9262) :1069-1075

[6]

Jones D E, 1998, Clin Liver Dis, V2, P265, DOI 10.1016/S1089-3261(05)70007-6

[7] Serum aminotransferase concentration as evidence of hepatocellular damage [J].

Kew, MC .

LANCET, 2000, 355 (9204) :591-592

[8]

Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4

[9] NASH: From liver diseases to metabolic disorders and back to clinical hepatology [J].

Marchesini, G ;

Forlani, G .

HEPATOLOGY, 2002, 35 (02) :497-499

[10] Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology [J].

Skelly, MM ;

James, PD ;

Ryder, SD .

JOURNAL OF HEPATOLOGY, 2001, 35 (02) :195-199

← 1 2 →